Previous Article | Next Article ![]()
Applied and Environmental Microbiology, October 2002, p. 4996-5004, Vol. 68, No. 10
0099-2240/02/$04.00+0 DOI: 10.1128/AEM.68.10.4996-5004.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.
Henk-jan Schoonbeek,
and Maarten A. De Waard*
Laboratory of Phytopathology, Wageningen University, 6700 EE Wageningen, The Netherlands
Received 28 March 2002/ Accepted 19 July 2002
|
|
|---|
|
|
|---|
Recently we demonstrated that B. cinerea possesses multiple ABC and MFS transporter genes (16, 33) and showed that the ABC transporter BcatrB plays a role in protection against the plant defense compound resveratrol and phenylpyrrole fungicides (29). Similarly, the ABC transporter BcatrD provides protection against DMIs (17). Overexpression of these transporters in laboratory-generated mutants resulted in multidrug resistance to fungicides and unrelated chemicals (16). This mechanism may also apply to fungicide resistance development under field conditions (7, 19).
In this paper, we describe the isolation of the MFS gene Bcmfs1 from B. cinerea. We constructed Bcmfs1 replacement and overexpression mutants and phenotyped these mutants for sensitivity to compounds from different chemical classes. The differential sensitivity of the mutants to the DMI fungicide oxpoconazole correlated with expression levels of Bcmfs1 and with accumulation of the fungicide by germlings of the mutants. We propose that Bcmfs1 functions in protection against natural toxins, DMI fungicides, and other unrelated compounds. Hence, Bcmfs1 is the first MFS multidrug transporter of a filamentous fungus for which multiple substrates have been described.
|
|
|---|
|
View this table: [in a new window] |
TABLE 1. B. cinerea strains used in this study
|
Compounds.
Oxpoconazole, iprodione, and prochloraz (technical grade) were obtained from Ube Industries, Ltd. (Ube, Yamaguchi, Japan), captan and tebuconazole were obtained from Bayer AG (Leverkusen, Germany), cyprodinil and pyrifenox were obtained from Syngenta (Stein, Switzerland), fenarimol was obtained from Eli Lilly and Company (Indianapolis, Ind.), and fluazinam was obtained from ISK Bioscience Co. (Mentor, Ohio). Barbaloin, camptothecin, cercosporin, colchicine, cycloheximide, 8-methoxypsoralen, reserpine, rhodamine 6G, rose bengal, toluidine blue, and vincamine were purchased from Sigma (St. Louis, Mo.), globulol and patchoulol were purchased from Fluka Chemie AG (Buchs, Switzerland), and hypericin and pseudohypericin were purchased from Planta Naturstoffe (Vienna, Austria).
Cloning of Bcmfs1.
Cloning of Bcmfs1 was performed following an approach similar to that described for BcatrD (17). An Expressed Sequence Tags (EST) fragment of Bcmfs1 (Fig. 1A) obtained by PCR amplification was used for screening of a genomic library of strain SAS56 in
EMBL3, provided by A. ten Have (Laboratory of Phytopathology, Wageningen University). Positive and purified phages were subcloned in pBluescript II SK and sequenced. DNA manipulations were performed according to standard methods (25). Escherichia coli strain DH5
was used for propagation of the constructs.
![]() View larger version (31K): [in a new window] |
FIG. 1. Physical map of Bcmfs1 in genomic DNA from B. cinerea wild-type strain B05.10 (A) and replacement mutant of Bcmfs1 with the hygromycin-resistance (OHT) cassette (B) or the nourseothricin-resistance (ONT) cassette (C). Southern blots of DNA from single-replacement mutants and double-replacement mutants of Bcmfs1 were hybridized with the 5.5-kb XbaI-SalI fragment and the 3.6-kb XbaI-ApaI fragment, respectively. Northern blots were hybridized with the EST fragment of Bcmfs1.
|
Construction of Bcmfs1 replacement mutants.
In an 8.5-kb XbaI-SalI subclone containing the full-length Bcmfs1 gene and its flanking regions, the 2.4-kb EcoRV fragment containing Bcmfs1 was replaced by the hygromycin-resistance cassette (OHT cassette) from pLOB1 to construct the replacement vector p
1-H (Fig. 1B). Before transformation, the plasmid was linearized with XhoI. Transformation was performed as described for replacement of the BcatrD gene (17).
Construction of double-replacement mutants.
In an 8.5-kb XbaI-SalI subclone, the 1.1-kb SacI-ClaI fragment was replaced by the nourseothricin resistance cassette (ONT cassette) from pNR to construct the replacement vector p
1-N (Fig. 1C). For the construction of double-replacement mutants, protoplasts from
BcatrB4 (29) or
BcatrD-8 (17) were transformed with 1 µg of p
1-N. Before transformation, the plasmid was linearized with XhoI. The selection and purification of putative transformants were performed by three successive transfers on malt extract agar amended with 100 mg of nourseothricin (Werner-Bioagents) liter-1 followed by single-spore isolation.
Construction of Bcmfs1 overexpression mutants.
A subclone containing the 5.5-kb XbaI-SalI fragment (Fig. 1A) in pBluescript II SK was used to generate overexpression mutants by cotransformation with pLOB1 to protoplasts of B05.10 as described previously (17).
Southern and Northern blot analysis.
Southern and Northern blot analyses were performed as described previously (17). In Southern blot experiments, 5 µg of genomic DNA was digested with EcoRV and hybridized with the 5.5-kb XbaI-SalI probe to characterize Bcmfs1 single-replacement mutants or the 3.6-kb XbaI-ApaI probe to characterize double-replacement mutants as presented in Fig. 1A. In Northern expression analysis experiments, 10 µg of total RNA was loaded on agarose gel (1.6%), and the blots were hybridized with the EST fragment of Bcmfs1 (Fig. 1A).
Phenotype assay.
The phenotype of replacement and overexpression mutants was studied by investigating their sensitivity to compounds in radial growth experiments as described previously (7). Drops of spore suspension (3 µl) of B. cinerea (106 conidia ml-1) were inoculated on plates with synthetic medium amended with chemicals from 100x concentrated stock solutions in methanol. The plates were incubated at 20°C in the dark for 3 days. The sensitivity to camptothecin, cercosporin, and other photosensitizers was investigated in the light as well as in the dark. Effective concentrations inhibiting radial growth by 50% (EC50s) of chemicals were calculated from dose-response curves using Excel 97. Experiments were repeated three times, and statistical analysis of the EC50s was performed by the least-significant-difference test (t test).
Accumulation of oxpoconazole.
Accumulation experiments were performed as described previously (13). Germling suspensions (4 mg wet weight per ml) in 0.05 M potassium phosphate buffer (pH 6.0) containing D-glucose (10 g liter-1) were preincubated on a reciprocal shaker at 20°C and 180 rpm for 20 min. [14C]oxpoconazole (initial external concentration, 30 µM; 750 Bq nmol-1) was added from a 100x concentrated stock solution in methanol. Samples (5 ml) taken from the suspensions at various time intervals were collected and washed three times with the same buffer on a GF6 microfiber glass filter (Schleicher & Schuell, Dassel, Germany). Radioactivity in mycelium was extracted with scintillation liquid (LUMASAFE PLUS, LUMAC*LSC B.V., Groningen, The Netherlands) for 1 day and counted in a liquid scintillation spectrometer BECKMAN LS6000TA (Beckman Coulter Inc., Fullerton, Calif.).
Virulence assay.
Detached leaves of tomato (cv. Moneymaker Cf4) were placed in florist foam on wet paper in plastic chambers. Drops of spore suspensions (1 µl) of B. cinerea (2 x 106 conidia ml-1) in B5 medium [1% sucrose, 10 mM (NH4)H2PO4, 0.31% Gamborg B5 medium elements (Duchefa, Haarlem, The Netherlands)] were spotted onto the surface of the tomato leaves. The wild-type isolate B05.10 and the mutants were inoculated on two halves of the same leaf. Inoculated leaves were incubated in closed boxes at 20°C in the dark. Diameters of lesions were measured 3 days after inoculation. Experiments were performed twice.
Nucleotide sequence accession number.
The full-length Bcmfs1 gene of B. cinerea has been submitted to GenBank under accession number AF238225.
|
|
|---|
The BLAST database (http://www.ncbi.nlm.nih.gov/BLAST/) provided by the National Center for Biotechnology Information demonstrated that Bcmfs1 is homologous to other MFS transporters, such as aflT from Aspergillus parasiticus (54.1% identity), CFP1 from C. kikuchii (36.6% identity), TOXA from C. carbonum (35.4% identity), and ORF10 from Aspergillus terreus (35.6% identity). Hydropathy analysis (http://www.ch.embnet.org/software/TMPRED_form.html) provided by the Swiss Institute of Bioinformatics predicts that Bcmfs1 has 14 transmembrane domains (data not shown).
Bcmfs1 single-replacement mutants.
Protoplasts of B. cinerea strain B05.10 were transformed with linearized p
1-H (Fig. 1B). Thirty putative transformants were selected and purified by single-spore isolation. Southern blot analysis of genomic DNA from these transformants revealed that several strains were homokaryotic transformants with a site-specific integration, including
Bcmfs1-16 and
Bcmfs1-18 (Fig. 2A). The reference strain HR-9 carrying the OHT cassette and BcatrD replacement mutant
BcatrD-8 (17) showed the same bands as the parental strain, B05.10 (Fig. 2A). The expression of the Bcmfs1 replacement mutants
Bcmfs1-16 and
Bcmfs1-18 was investigated by Northern analysis with the EST fragment of Bcmfs1 (Fig. 1A) as a probe. The basal level of expression of Bcmfs1 in the parental strain B05.10, the reference strain HR-9, and
BcatrD-8 was low but strongly induced after treatment of germlings with oxpoconazole (30 mg liter-1) for 60 min. In
Bcmfs1-16 and
Bcmfs1-18, neither basal nor oxpoconazole-induced expression was observed (Fig. 3A).
![]() View larger version (110K): [in a new window] |
FIG. 2. Southern blot analysis of DNA from B. cinerea. Genomic DNA (5 µg) was digested with EcoRV and hybridized with a 5.5-kb XbaI-SalI probe (A) and with a 3.6-kb XbaI-ApaI probe (B). Results obtained with parental strain B05.10, Bcmfs1 replacement mutants Bcmfs1-16 and Bcmfs1-18, reference mutant HR-9, BcatrD replacement mutant BcatrD-8, BcatrB and Bcmfs1 double-replacement mutant B 1-22, BcatrD and Bcmfs1 double-replacement mutant D 1-45, reference mutant HNR-4, and BcatrB replacement mutant BcatrB4 are shown.
|
![]() View larger version (84K): [in a new window] |
FIG. 3. Northern blot analysis of total RNA (10 µg) from germlings of B. cinerea. (A) Parental strain B05.10, Bcmfs1 replacement mutants Bcmfs1-16 and Bcmfs1-18, reference mutant HR-9, and BcatrD replacement mutant BcatrD-8. Basal levels of expression (lanes 1) and expression levels after treatment with 30 mg of oxpoconazole liter-1 (lanes 2) are shown. (B) Parental strain B05.10, BcatrB and Bcmfs1 double-replacement mutant B 1-22, BcatrD and Bcmfs1 double-replacement mutant D 1-45, reference mutant HNR-4, BcatrB replacement mutant BcatrB4, BcatrD replacement mutant BcatrD-8, and Bcmfs1 replacement mutant Bcmfs1-16. Basal levels of expression (lanes 1) and expression levels after treatment with 30 mg of oxpoconazole liter-1 (lanes 2) are shown. (C) Parental strain B05.10 (lanes 1) and the Bcmfs1 overexpression mutants OV1-23 (lanes 2), OV1-48 (lanes 3), and OV1-13 (lanes 4). Basal and induced expression levels after treatment with 3, 10, and 30 mg of oxpoconazole liter-1 are shown. RNA was hybridized with the EST probe specific for Bcmfs1 (Fig. 1A). Equal loading of lanes with RNA was checked by subsequently probing the same blot with 28S rRNA.
|
Bcmfs1-16 and
Bcmfs1-18 had an increased sensitivity to the alkaloid camptothecin (a fungitoxic compound from Camptotheca acuminata) and the perylenequinone cercosporin (a host-specific toxin produced by C. kikuchii), while the reference strain HR-9 displayed almost the same sensitivity to these compounds as the parental strain, B05.10 (Fig. 4A; Table 2). As expected, the fungitoxic activity of the photosensitizer cercosporin was higher in the light than in the dark (Fig. 5). The fungitoxic activity of other photosensitizers, such as cercosporin analogues (hypericin and pseudohypericin), rose bengal, toluidine blue, 8-methoxypsoralen, and alkaloids (barbaloin, colchicine, reserpine, and vincamine), was similar for all strains tested and was not influenced by light (data not shown). The activity of fungicides (captan, cyprodinil, fluazinam, iprodione, oxpoconazole, prochloraz, and tebuconazole) and other fungitoxic compounds (cycloheximide and rhodamine 6G) was similar for the wild-type strain and all Bcmfs1 single-replacement mutants tested (results shown only for
Bcmfs1-16 in Table 2). Similar results were obtained with the botrydial analogues patchoulol or globulol (32) (data not shown).
![]() View larger version (93K): [in a new window] |
FIG. 4. Activity of compounds in radial growth experiments. (A) Parental strain B05.10, reference mutant HR-9, and Bcmfs1 replacement mutants Bcmfs1-16 and Bcmfs1-18. (B) Reference mutant HNR-4, single gene replacement mutants ( BcatrB4, BcatrD-8, and Bcmfs1-16), and double gene replacement mutants ( B 1-22 and D 1-45). (C) Wild-type strain B05.10 and Bcmfs1 overexpression mutants (OV1-23, OV1-48, and OV1-13).
|
|
View this table: [in a new window] |
TABLE 2. Activity of compounds on radial growth of B. cinerea
|
![]() View larger version (38K): [in a new window] |
FIG. 5. Activity of cercosporin and camptothecin on relative growth of B. cinerea wild-type strain B05.10 (+), reference transformant HR-9 (x), two Bcmfs1 replacement mutants, Bcmfs1-16 () and Bcmfs1-18 ( ), and Bcmfs1 overexpression mutants OV1-23( ), OV1-48 ( ), and OV1-13 ( ).
|
BcatrB4 (29) and the BcatrD replacement mutant
BcatrD-8 (17) were transformed with linearized p
1-N (Fig. 1C). Southern analysis of genomic DNA from the putative transformants digested with EcoRV revealed that
B
1-22 and
D
1-45 were homokaryotic transformants (Fig. 2B). Northern analysis of the transformants demonstrated that basal and oxpoconazole-induced expression of Bcmfs1 was not detectable in mutants
B
1-22 and
D
1-45 (Fig. 3B).
The sensitivity of the double-replacement mutant
D
1-45 to the DMI fungicide oxpoconazole was higher than that of the single-replacement mutant
BcatrD-8 (Fig. 4B; Table 3). This was not observed for the double-replacement mutant
B
1-22 (Fig. 4B). Differential activities against
D
1-45 and
BcatrD-8 were also observed with other DMI fungicides, such as fenarimol, prochloraz, pyrifenox, and tebuconazole (Table 3). In contrast, camptothecin did have activity similar to that of
Bcmfs1-16,
B
1-22, and
D
1-45 (Fig. 4B).
|
View this table: [in a new window] |
TABLE 3. Activity of compounds on radial growth of B. cinerea
|
Overexpression mutants possessed a decreased sensitivity to camptothecin, cercosporin, DMI fungicides, cyprodinil, iprodione, captan, and fluazinam compared to wild-type strain B05.10. Surprisingly, the same mutant showed an increased sensitivity to the antibiotic cycloheximide (Fig. 4C; Table 2).
Accumulation of oxpoconazole.
The accumulation of oxpoconazole by germlings of B. cinerea wild-type strain B05.10 was transient in time. The mutants tested also showed this phenomenon, though to a varying extent. The initial accumulation (up to 40 min of incubation) of oxpoconazole by all strains tested correlated with sensitivity to oxpoconazole in radial growth experiments (Fig. 6; Tables 2 and 3). The correlation coefficient (r2) between accumulation of oxpoconazole after 20 min of incubation and the EC50 of oxpoconazole for the different strains was calculated to be 0.813. Strikingly, the steady-state level of accumulation of oxpoconazole (after 60 min of incubation) by
BcatrD-8 and
D
1-45 always remained higher than that by all other strains tested (Fig. 6). Furthermore, the level of accumulation by
D
1-45 was significantly higher than that by
BcatrD-8.
![]() View larger version (28K): [in a new window] |
FIG. 6. Accumulation of oxpoconazole (30 µM) by germlings of B. cinerea wild-type strain B05.10 (+), reference transformant HNR-4 (x), BcatrD single-replacement mutants BcatrD-8 ( ), Bcmfs1 single-replacement mutants Bcmfs1-16 ( ), BcatrD and Bcmfs1 double-replacement mutant D 1-45 (), and Bcmfs1 overexpression mutants OV1-13 ( ).
|
Bcmfs1-16,
Bcmfs1-18,
B
1-22,
D
1-45, OV1-23, OV1-48, OV1-13, HR-9, and HNR-4) on detached tomato leaves was similar to that of the parental strain, B05.10 (data not shown). |
|
|---|
Bcmfs1 has a high homology with aflT from A. parasiticus, CFP1 from C. kikuchii, and TOXA from C. carbonum. The homology with CFP1 may reflect why both Bcmfs1 and CFP1 are involved in protection against cercosporin. Like Bcmfs1, MFS proteins from yeasts, such as BenR (15) and FLU1 (5) from C. albicans and FLR1 (1) from S. cerevisiae, transport DMI fungicides. However, these three yeast MFS proteins have a low level of homology to Bcmfs1, suggesting that there is no obvious relation between homology and substrate specificity.
The role of bcmfs1 in transport of DMI fungicides became obvious only after functional inactivation in a
BcatrD mutant (Fig. 4B; Table 3). A similar phenomenon has been reported with C. albicans for the ABC transporter CDR2, which showed a phenotype only in mutants with a
CDR1 background (28). This can be ascribed to redundancy of transporters with an overlap in substrate specificity. Previously, we demonstrated that BcatrD is the major transporter of DMI fungicides in B. cinerea (17). Hence, we assume that the lack of phenotype of
Bcmfs1 mutants with respect to sensitivity to DMIs is due to compensating activity of BcatrD. However, such compensating activity does not seem to be accompanied by increased transcription of BcatrD, since basal and induced transcript levels of the gene were similar in strains B05.10 and
Bcmfs1-16 (Fig. 3B). The conclusion that Bcmfs1 mediates transport of DMIs is supported by the observation that the Bcmfs1-overexpressing mutants showed a significant reduction in DMI sensitivity (Fig. 4C; Table 2). BcatrB is not a DMI transporter (29, 33). Still, expression of BcatrB is induced by treatment with DMI fungicides (16), indicating that inducers of expression of BcatrB are not necessarily a substrate of the encoded proteins. Similar phenomena have been described for other ABC genes (17, 29).
Bcmfs1-overexpressing mutants display reduced sensitivity to various unrelated fungicides (Fig. 4C; Table 2). This suggests that the multidrug transporter Bcmfs1 has a low substrate specificity for these products and that loss of the Bcmfs1 function in deletion mutants can be compensated for by other transporters. Mutant OV1-13 has a slightly increased sensitivity to cycloheximide (Fig. 4C; Table 2). A similar phenomenon was observed in multidrug-resistant mutants of A. nidulans with resistance to DMIs and increased sensitivity to dithiocarbamate fungicides and the antibiotic phleomycin (3). We hypothesize that the increased sensitivity displayed by the overexpression mutant could be due to the fact that MFS transporters function as not only efflux but also influx transporters (14).
The accumulation of oxpoconazole by germlings of B. cinerea was transient in time. The initial accumulation (up to 40 min) by OV1-13 was lower than that by B05.10 (Fig. 6), and the accumulation by all strains correlated with their sensitivity to the fungicide (Fig. 6; Tables 2 and 3). The steady-state level of oxpoconazole accumulation (after 60 min) by
D
1-45 was significantly higher than that by
BcatrD-8. These observations indicate that mutations in Bcmfs1 indeed functionally affect efflux of oxpoconazole. Besides BcatrD and Bcmfs1, additional transporters in B. cinerea may exist that play a role in efflux of DMI fungicides. This assumption is based on the observation that the double-replacement mutant
D
1-45 still displays a transient accumulation profile (Fig. 6), which suggests that efflux activity still proceeds to a weak extent. The transporter gene involved might be BcatrG and/or BcatrK, since expression of these genes was induced by DMI fungicides (16). Such a situation would indicate that multiple transporter proteins mediate the transport of a particular compound. A similar phenomenon has been described for C. albicans, which possesses at least four transporter genes involved in efflux of DMIs. These include the ABC transporter genes CDR1 (24) and CDR2 (27) and the MFS genes CaBenR (26) and FLU1 (5).
It is probable that B. cinerea developed transporter systems during evolution to cope with natural toxic compounds. However, in this context it is difficult to understand why camptothecin and cercosporin are substrates of Bcmfs1. Camptothecin is an alkaloid compound with antitumor activity isolated from Chinese tree C. acuminata. This plant is not known as a host of B. cinerea. It might be that plant species within the wide host range of B. cinerea contain the same or related alkaloids. Cercosporin is a natural photoactivated toxin produced by Cercospora species (9), and similar compounds are not known for B. cinerea. It is not likely that they are produced during pathogenesis, since necrotic symptoms incited by B. cinerea are light independent. Bcmfs1 is also not a general transporter of photosensitizers, as shown for Snq2 (34). Hence, the potency of Bcmfs1 for transport of cercosporin is hard to explain. A number of MFS transporters from filamentous fungi homologous to Bcmfs1 can function as virulence factors. This is reported for the cercosporin transporter from C. kikuchii (6), the HC toxin transporter from C. carbonum (23), and the transporter of trichothecenes from F. sporotrichioides (2). MFS genes involved in secretion of HC toxin and trichothecenes are located in a gene cluster carrying genes that encode enzymes involved in biosynthesis of these toxins. A role for Bcmfs1 in secretion of endogenous toxins is not obvious, since DNA sequences flanking Bcmfs1 did not reveal the presence of genes involved in toxin biosynthesis. Botrydial, produced by B. cinerea, is toxic to sweet pepper (10). This toxin might be a substrate of Bcmfs1, although disruption of Bcmfs1 did not increase the sensitivity to botrydial analogues, such as patchoulol and globulol (32). The virulence of all Bcmfs1 mutants tested on detached tomato leaves was similar to that of the parental strain, B05.10. For these reasons, the intrinsic function of Bcmfs1 is still obscure. Such a function might become obvious upon testing the virulence of replacement mutants on a wide range of host plants. These studies are being performed in current research, but so far no phenotype with respect to host virulence has been found. It is also possible that Bcmfs1 functions in protection against antibiotics produced by antagonistic microorganisms during its saprophytic phase of growth. Such a function has recently been reported for BcatrB of B. cinerea in protection against phenazine antibiotics produced by Pseudomonas species (30). This hypothesis is currently being tested for Bcmfs1 and other ABC and MFS transporters of B. cinerea.
Present address: Ube Research Laboratory, Ube Industries, Ltd., 1978-5 Kogushi, Ube, Yamaguchi, Japan. ![]()
Present address: Department of Plant Biology, University of Fribourg, CH-1700 Fribourg, Switzerland. ![]()
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»